Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Current

    • Oryzon KOL Event to Discuss Topline Results from Phase IIb PORTICO Study of Vafidemstat in Borderline Personality Disorder

    Join Oryzon Genomics for a virtual KOL Event to briefly review, then discuss the topline results from the Phase IIb…
    TIME: 10:00 AM EST
    LOCATION: Virtual
    View Details

    Vera Therapeutics In-Person R&D Day: Week 72 Data from Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN

    Join Vera Therapeutics for a hybrid R&D day, featuring Richard Lafayette, MD, FACP, from Stanford University Medical Center, who will join company management…
    TIME: 8:00 AM EST
    LOCATION: Lotte New York Palace Hotel, 455 Madison Ave
    New York, 10022 United States
    View Details

    eFFECTOR Therapeutics Virtual Investor R&D Day: Development Progress for Tomivosertib and Zotatifin, Including a Review of Phase 2 Data of Zotatifin in ER+ Metastatic Breast Cancer and Anticipated 2024 Milestones

    Join eFFECTOR Therapeutics for a virtual investor R&D day which will feature presentations by eFFECTOR management and Dr. Kevin Kalinsky,…
    TIME: 4:30 PM EST
    LOCATION: Virtual
    View Details

    13th Annual LifeSci Partners Corporate Access Event

    LifeSci Partners invites you to register for our 13th Annual Corporate Access Event Featuring more than 150 publicly trading and…
    TIME: 8:00 AM - 6:00 PM PST
    LOCATION: Beacon Grand Hotel, San Francisco, CA
    View Details

    Oryzon Data Call to Discuss Topline Results from Phase IIb PORTICO Study of Vafidemstat in Borderline Personality Disorder

    Join Oryzon Genomics for a data call to discuss topline results from the Phase IIb PORTICO study evaluating vafidemstat in…
    TIME: 5:30 PM PST
    LOCATION: Virtual
    View Details

    Aspira R&D Day: Updates on the Development of the Company’s Ovarian Cancer and Endometriosis Tests

    Join us for a virtual R&D Day with Aspira Women’s Health, featuring experts who will present the exciting progress of…
    TIME: 11:00 AM EST
    LOCATION: Virtual
    View Details

    • Nusano Virtual KOL Event on Emerging Trends in Radiotherapeutics: Beyond Lu-177 and Ac-225

    Join Nusano for a virtual KOL panel discussion led by Suji Jeong, PhD (Founding Partner, The SJR Group), featuring Phil Nicklin (Senior Analyst, LifeSci Consulting), Dr.…
    TIME: 11:00 AM EST
    LOCATION: Virtual
    View Details

    Mendus KOL Event to Review Phase 2 Data with Vididencel in Acute Myeloid Leukemia Presented at ASH 2023

    Join us for a virtual KOL Event with Mendus, featuring Dr. Arjan van de Loosdrecht, Professor of Hematology at Amsterdam UMC, who…
    TIME: 9:00 AM EST
    LOCATION: Virtual
    View Details

    BioAtla Virtual R&D Day: BA3071 CAB-CTLA-4 Phase 1 Data Review in Multiple Solid Tumor Types

    Join us for a Virtual R&D Day with BioAtla, featuring Omid Hamid, MD (Cedars Sinai: The Angeles Clinic and Research…
    TIME: 10:00 AM EST
    LOCATION: Virtual
    View Details

    Shattuck Labs Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline HR-MDS and TP53m AML and Review of Dose-Escalation Data from ASH 2023 Annual Meeting

    Join Shattuck Labs, Inc. for a data call to present the initial data from the frontline expansion cohorts in HR-MDS…
    TIME: 8:00 AM EST
    LOCATION: Virtual
    View Details

    Hybrid Ligand In-Person Investor Day: Updates on Ligand’s Strategy, Portfolio, and Financial Outlook

    Join the Ligand Pharmaceuticals Annual Investor Day in-person or via webcast, discussing Ligand's strategy, portfolio, and financial outlook supporting the clinical development of…
    TIME: 10:30 AM EST
    LOCATION: Harvard Club, 35 W 44th St, New York
    View Details

    Virtual TScan Therapeutics Virtual KOL Event: Initial results from Phase 1 Trial of TSC-100 and TSC-101 Presented at ASH 2023 and Potential for TCR-T Therapies in Cancer

    Join TScan Therapeutics for a virtual KOL event, featuring Monzr M. Al Malki, MD (City of Hope) who will review the initial…
    TIME: 8:00 AM EST
    LOCATION: Virtual
    View Details

    Galapagos In-Person KOL Event to Discuss New Data Presented at ASH 2023

    Time: 11:00 AM - 12:30 PM PST Join Galapagos for an in-person KOL event during the 65th ASH Annual Meeting…
    TIME: 11:00 AM PST
    LOCATION: San Diego Marriott Gaslamp Quarter, Presidio Ballroom B/C - 660 K Street, San Diego, California, USA, 92101
    View Details

    Codexis Virtual KOL Event: The ECO Synthesis™ Platform and The Future of RNAi Therapeutics Manufacturing

    Join Codexis for a virtual KOL event featuring John Maraganore, PhD (Founder and Former Chief Executive Officer of Alnylam Pharmaceuticals) and David Butler, PhD (Chief…
    TIME: 10:00 AM EST
    LOCATION: Virtual
    View Details

    Lumos Pharma Virtual KOL Event: Review of Phase 2 OraGrowtH Trials and New Analyses of Oral LUM-201 for Pediatric Growth Hormone Deficiency

    Join Lumos Pharma for a virtual KOL event featuring Andrew Dauber, M.D., M.M.Sc.,(Children’s National Hospital), Fernando Cassorla, M.D. (Institute of…
    TIME: 1:30 PM EST
    LOCATION: Virtual
    View Details

    Sol-Gel Virtual KOL Event: Preventing Basal Cell Carcinomas Associated with Gorlin Syndrome: A Discussion of the Disease Burden, SGT-610 and the Upcoming Phase 3 Trial

    Join us for a virtual KOL event with Sol-Gel Technologies, featuring Julie Breneiser (Executive Director, Gorlin Syndrome Alliance) and Ervin Epstein Jr., MD…
    TIME: 12:00 PM EST
    LOCATION: Virtual
    View Details